Figure 6From: The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical studyPI/I ratio in mitiglinide responders (non-responders). PI/I ratio was reduced significantly in the responder group (a). PI/I ratio did not change in the non-responder group (b).Back to article page